Literature DB >> 27030919

Lethal neonatal meningoencephalitis caused by multi-drug resistant, highly virulent Escherichia coli.

Junaid Iqbal1, Kevin R Dufendach1, John C Wellons2, Maria G Kuba3, Hilary H Nickols3, Oscar G Gómez-Duarte1, James L Wynn4.   

Abstract

Neonatal meningitis is a rare but devastating condition. Multi-drug resistant (MDR) bacteria represent a substantial global health risk. This study reports on an aggressive case of lethal neonatal meningitis due to a MDR Escherichia coli (serotype O75:H5:K1). Serotyping, MDR pattern and phylogenetic typing revealed that this strain is an emergent and highly virulent neonatal meningitis E. coli isolate. The isolate was resistant to both ampicillin and gentamicin; antibiotics currently used for empiric neonatal sepsis treatment. The strain was also positive for multiple virulence genes including K1 capsule, fimbrial adhesion fimH, siderophore receptors iroN, fyuA and iutA, secreted autotransporter toxin sat, membrane associated proteases ompA and ompT, type II polysaccharide synthesis genes (kpsMTII) and pathogenicity-associated island (PAI)-associated malX gene. The presence of highly-virulent MDR organisms isolated in neonates underscores the need to implement rapid drug resistance diagnostic methods and should prompt consideration of alternate empiric therapy in neonates with Gram negative meningitis.

Entities:  

Keywords:  Escherichia coli; hypervirulence; meningitis; meningoencephalitis; multi-drug resistance; neonate

Mesh:

Substances:

Year:  2016        PMID: 27030919      PMCID: PMC4818964          DOI: 10.3109/23744235.2016.1144142

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  36 in total

Review 1.  Fourteen years in resistance.

Authors:  David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2012-03-03       Impact factor: 5.283

Review 2.  Neonatal infections due to multi-resistant strains: Epidemiology, current treatment, emerging therapeutic approaches and prevention.

Authors:  Chryssoula Tzialla; Alessandro Borghesi; Margherita Pozzi; Mauro Stronati
Journal:  Clin Chim Acta       Date:  2015-03-04       Impact factor: 3.786

Review 3.  Proliferation and significance of clinically relevant β-lactamases.

Authors:  Karen Bush
Journal:  Ann N Y Acad Sci       Date:  2013-01       Impact factor: 5.691

Review 4.  The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.

Authors:  Amy J Mathers; Gisele Peirano; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  Genotypic and phenotypic traits that distinguish neonatal meningitis-associated Escherichia coli from fecal E. coli isolates of healthy human hosts.

Authors:  Catherine M Logue; Curt Doetkott; Paul Mangiamele; Yvonne M Wannemuehler; Timothy J Johnson; Kelly A Tivendale; Ganwu Li; Julie S Sherwood; Lisa K Nolan
Journal:  Appl Environ Microbiol       Date:  2012-06-15       Impact factor: 4.792

6.  Quantitative biofilm assay using a microtiter plate to screen for enteroaggregative Escherichia coli.

Authors:  Naoko Wakimoto; Junichiro Nishi; Jalaluddin Sheikh; James P Nataro; Jav Sarantuya; Mayumi Iwashita; Kunihiro Manago; Koichi Tokuda; Masao Yoshinaga; Yoshifumi Kawano
Journal:  Am J Trop Med Hyg       Date:  2004-11       Impact factor: 2.345

7.  The capsule supports survival but not traversal of Escherichia coli K1 across the blood-brain barrier.

Authors:  J A Hoffman; C Wass; M F Stins; K S Kim
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

8.  Combined multilocus sequence typing and O serogrouping distinguishes Escherichia coli subtypes associated with infant urosepsis and/or meningitis.

Authors:  Philippe Bidet; Farah Mahjoub-Messai; Jorge Blanco; Jesús Blanco; Marie Dehem; Yannick Aujard; Edouard Bingen; Stéphane Bonacorsi
Journal:  J Infect Dis       Date:  2007-06-04       Impact factor: 5.226

9.  Functional characterization of the antibiotic resistance reservoir in the human microflora.

Authors:  Morten O A Sommer; Gautam Dantas; George M Church
Journal:  Science       Date:  2009-08-28       Impact factor: 47.728

10.  The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups.

Authors:  Olivier Clermont; Julia K Christenson; Erick Denamur; David M Gordon
Journal:  Environ Microbiol Rep       Date:  2012-12-24       Impact factor: 3.541

View more
  12 in total

1.  Phylogenomic Analysis of Extraintestinal Pathogenic Escherichia coli Sequence Type 1193, an Emerging Multidrug-Resistant Clonal Group.

Authors:  Timothy J Johnson; Ehud Elnekave; Elizabeth A Miller; Jeannette Munoz-Aguayo; Cristian Flores Figueroa; Brian Johnston; Daniel W Nielson; Catherine M Logue; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

2.  Escherichia coli K1 Modulates Peroxisome Proliferator-Activated Receptor γ and Glucose Transporter 1 at the Blood-Brain Barrier in Neonatal Meningitis.

Authors:  Subramanian Krishnan; Alexander C Chang; Brian M Stoltz; Nemani V Prasadarao
Journal:  J Infect Dis       Date:  2016-07-24       Impact factor: 5.226

3.  Raman microspectroscopy differentiates perinatal pathogens on ex vivo infected human fetal membrane tissues.

Authors:  Oscar D Ayala; Ryan S Doster; Shannon D Manning; Christine M O'Brien; David M Aronoff; Jennifer A Gaddy; Anita Mahadevan-Jansen
Journal:  J Biophotonics       Date:  2019-06-19       Impact factor: 3.207

4.  Comparative Pathogenomics of Escherichia coli: Polyvalent Vaccine Target Identification through Virulome Analysis.

Authors:  J R Clark; A M Maresso
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

5.  Complete Genome Sequence of the Multidrug-Resistant Neonatal Meningitis Escherichia coli Serotype O75:H5:K1 Strain mcjchv-1 (NMEC-O75).

Authors:  Daniel W Nielsen; Nicole Ricker; Nicolle L Barbieri; James L Wynn; Oscar G Gómez-Duarte; Junaid Iqbal; Lisa K Nolan; Heather K Allen; Catherine M Logue
Journal:  Microbiol Resour Announc       Date:  2018-09-13

6.  Septic shock due to Escherichia coli meningoencephalitis treated with immunoglobulin-M-enriched immunoglobulin preparation as adjuvant therapy: a case report.

Authors:  V Pota; M B Passavanti; F Coppolino; F Di Zazzo; L De Nardis; R Esposito; M Fiore; G S R C Mangoni di Santostefano; C Aurilio; P Sansone; M C Pace
Journal:  J Med Case Rep       Date:  2021-03-29

7.  Streptococcus agalactiae Induces Placental Macrophages To Release Extracellular Traps Loaded with Tissue Remodeling Enzymes via an Oxidative Burst-Dependent Mechanism.

Authors:  David M Aronoff; Jennifer A Gaddy; Ryan S Doster; Jessica A Sutton; Lisa M Rogers
Journal:  mBio       Date:  2018-11-20       Impact factor: 7.867

8.  Secreted autotransporter toxin (Sat) induces cell damage during enteroaggregative Escherichia coli infection.

Authors:  Paulo C G Vieira; Abraham O Espinoza-Culupú; Roberto Nepomuceno; Marina R Alves; Ivo Lebrun; Waldir P Elias; Rita C Ruiz
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

Review 9.  Strategies to Tackle Antimicrobial Resistance: The Example of Escherichia coli and Pseudomonas aeruginosa.

Authors:  Giada Antonelli; Luigia Cappelli; Paolo Cinelli; Rossella Cuffaro; Benedetta Manca; Sonia Nicchi; Serena Tondi; Giacomo Vezzani; Viola Viviani; Isabel Delany; Maria Scarselli; Francesca Schiavetti
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

10.  In Vitro Characterization and In Vivo Efficacy Assessment in Galleria mellonella Larvae of Newly Isolated Bacteriophages against Escherichia coli K1.

Authors:  Céline Antoine; Fanny Laforêt; Bob Blasdel; Abdoulaye Fall; Jean-Noël Duprez; Jacques Mainil; Véronique Delcenserie; Damien Thiry
Journal:  Viruses       Date:  2021-10-06       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.